Clinical trial
Immunoinflammatory Response in Post Cardiac Arrest Syndrome (PCAS)
Recruiting now · Not applicable · 1 countries · Registry ID NCT02664831
What this study is about
This is a prospective, observational study to investigate molecular mechanisms mediating the systemic inflammatory process, and changes to metabolism, and their impact on brain injury, survival, and functional outcomes after cardiac arrest. Investigators have shown that cardiac arrest induces changes in the numbers and properties of circulating immune cells, shifting the balance towards a pro-inflammatory phenotype and there is increased interest in the inflammatory pathways and the signaling mechanisms through which they are modulated. Participants will undergo blood sampling during 7 days following cardiac arrest, and analyses performed. Patient characteristics, clinical circumstances, and outcomes will be recorded and their associations with these inflammatory pathways characterized.
Basic eligibility
Full registry criteria
Treatments and study arms
Primary outcomes
Correlations between inflammatory markers and clinical outcomes
Correlations between inflammatory markers and biomarkers of neurological and cardiac injury
Study locations
1 locations were listed when this page was built. The first 40 are shown.